The rising interest in GLP-1 agonists for metabolic conditions has led to a question about formats: skin-applied devices versus pills . Traditionally , GLP-1 treatments were exclusively available in oral https://diegolbcm018225.uzblog.net/glp-1-transdermal-delivery-systems-vs-pills-is-suitable-for-the-patient-54580039